
Pfizer’s modified COVID-19 vaccine for use in children under 5 was 73% effective in shielding them from infection during the Omicron surge this spring, company data released Tuesday shows. The specially formulated doses for America’s youngest children were approved for distribution in June, although the American Academy of Pediatrics says uptake has been low. Just… read on > read on >